203 filings
Page 2 of 11
8-K
n80x 269h5q3tix
14 Aug 23
Evofem Biosciences Announces Financial Results for the Second Quarter of 2023
5:25pm
8-K
fekf o6xydlgtphk8
10 Aug 23
Entry into a Material Definitive Agreement
5:29pm
8-K
86mbcec 4befqao
17 Jul 23
Material Modifications to Rights of Security Holders
4:05pm
8-K
kacn4p0pjq4ho2z99xm
10 Jul 23
Entry into a Material Definitive Agreement
5:16pm
8-K
48fk7n
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
bip2c1omjesdf
16 Jun 23
Evofem Biosciences Announces Financial Results for the First Quarter of 2023
4:01pm
8-K
7kazbj3p0z j0h
1 Jun 23
Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023
8:36am
8-K
8rqar
17 May 23
Evofem Biosciences Announces 1-for-125 Reverse Stock Split
5:13pm
8-K
46lt0gks2q vrscf1a
5 May 23
Other Events
5:00pm
8-K
kcsx 7dao4ocnl
28 Apr 23
Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update
6:50am
8-K
vaapm
14 Apr 23
Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary
9:05am
8-K/A
v5anspqp
11 Apr 23
Entry into a Material Definitive Agreement
8:17pm
8-K
8l1e0jrqjdjm pzf
10 Apr 23
Entry into a Material Definitive Agreement
5:26pm
8-K
gjjokdvh
24 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
025mph o1
20 Mar 23
Evofem Biosciences Announces Cost Reduction Measures
9:55pm
8-K
i3mvr
16 Mar 23
Submission of Matters to a Vote of Security Holders
7:07pm
8-K
rza97nj z56t
14 Mar 23
Entry into a Material Definitive Agreement
9:00am
8-K
tsvo7qq95bx4fdjf
10 Mar 23
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:27pm
8-K
zdofrr zq5
9 Mar 23
Evofem Biosciences Appoints Interim Chief Financial Officer
4:01pm
8-K
75cmb2mp dr
23 Feb 23
Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value
8:59pm